Pharma stocks a growing healthcare sub-segment
Singapore
EVEN though pharmaceuticals is one of the smaller sub-segments in the Singapore Exchange's (SGX's) cluster of healthcare stocks, its year-to-date market cap-weighted average total return of 7.3 per cent is almost double that of the 3.8 per cent generated by the SGX All Healthcare Index - the benchmark for listed healthcare companies here.
The six stocks are: Tianjin ZhongXin Pharmaceutical Group, Haw Par Corporation, iX Biopharma, Suntar Eco-City, Pharmesis International and Star Pharmaceutical.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
JPMorgan unveils IndexGPT in next Wall Street bid to tap AI boom
Morgan Stanley, Frasers settle UK lawsuit over US$1 billion margin call
Venture posts lower Q1 net profit of S$60.1 million on weaker demand
YHI International COO and subsidiary charged with alleged failure to ensure employee safety, causing death
India's markets regulator puts seven Adani companies on notice for violations
Singapore stocks end week in red; STI down 0.1%